IP
54
-13
XRX
45
-3
DHR
47
-2
EMC
89
-8
CHRW
44
-3
ABBV
64
-4
PGR
70
5
SYF
86
-4
UHS
62
2
AIZ
63
6
PFG
46
-2
RCL
73
-4
O
35
-2
PNW
46
-2
MMM
33
7
NOC
47
2
AVB
72
3
AVY
68
-3
THC
73
3
BLK
63
-3
IP
54
-13
XRX
45
-3
DHR
47
-2
EMC
89
-8
CHRW
44
-3
ABBV
64
-4
PGR
70
5
SYF
86
-4
UHS
62
2
AIZ
63
6
PFG
46
-2
RCL
73
-4
O
35
-2
PNW
46
-2
MMM
33
7
NOC
47
2
AVB
72
3
AVY
68
-3
THC
73
3
BLK
63
-3
Financhill
Back

Alexandria Real Estate Equities Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
55

ARE
Alexandria Real Estate Equities

Last Price:
116.05
Seasonality Move:
4.04%
Buy
54

SRPT
Sarepta Therapeutics

Last Price:
157.05
Seasonality Move:
18.65%
Buy
55
Alexandria Real Estate Equities (ARE) is a Buy

Is Alexandria Real Estate Equities a Buy, Sell or Hold?

  • The current Alexandria Real Estate Equities [ARE] share price is $116.39. The Score for ARE is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • ARE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $157.96. The Score for SRPT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ARE Stock Price Chart

What is Alexandria Real Estate Equities's stock price today?

  • The Alexandria Real Estate Equities share price today is $116.39
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $157.96
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

ARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.76 Sell
Relative Strength Index (14 RSI): 47.53 Sell
Chaikin Money Flow: 542707 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (114.78 - 118.46) Sell
Bollinger Bands (100): (116.35 - 124.47) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.07 Buy
Relative Strength Index (14 RSI): 68.93 Buy
Chaikin Money Flow: 909555 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (113.85 - 144.93) Buy
Bollinger Bands (100): (118.68 - 136.96) Buy

ARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 116.14 Buy
20-day SMA: 116.17 Buy
50-day SMA: 118.22 Sell
200-day SMA: 115.89 Buy
8-day EMA: 116.24 Buy
20-day EMA: 116.69 Sell
50-day EMA: 118.28 Sell
200-day EMA: 119.88 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 144.42 Buy
20-day SMA: 131.3 Buy
50-day SMA: 128.76 Buy
200-day SMA: 115.64 Buy
8-day EMA: 148.13 Buy
20-day EMA: 137 Buy
50-day EMA: 130.51 Buy
200-day EMA: 121.04 Buy

Alexandria Real Estate Equities Earnings Growth & ARE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.24 per share, an increase next quarter of $0.02 per share, a decrease this year of $6.40 per share, and an increase next year of $0.12 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.18 per share, an increase next quarter of $2.65 per share, an increase this year of $6.58 per share, and an increase next year of $8.28 per share.

Alexandria Real Estate Equities Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):